CXCR3 and CCR5 (receptors for CCL11) are expressed by T cells in MS lesions, while their ligands are expressed by microglia and vascular endothelial cells, reflecting T helper1 (Th1) cell infiltration [5]. Here, CCR5 is linked to myeloid sarcoma.